Deep grey matter `black T2` on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis

Abstract

T2 hypointensity (black T2, BT2) in the deep grey matter of multiple sclerosis (MS) patients correlate weakly with disability at 1.5 T. BT2 is likely to be caused by abnormal iron deposition. We compared the correlation between disability and deep grey matter BT2 measured on 3 T MRI and on 1.5 T MRI in 17 MS patients. We observed a significant correlation between expanded disability status scale and signal intensity on 3 T MRI in the globus pallidus and the caudate nucleus (r = —0.5, P < 0.05). BT2 at 3 T may be a useful MRI measure associated with disability in MS and warrants further study. Multiple Sclerosis 2007; 13: 880—883. http://msj.sagepub.com

Keywords

black T2 high field MRI multiple sclerosis disability deep grey matter iron deposition

Get full access to this article

View all access options for this article.

References

Drayer B. , Burger P. , Hurwitz B. , Dawson D. , Cain J.

Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content?

AJNR 1987 ; 8: 413—19.

Bakshi R. , Benedict Rhb , Bermel RA , Caruthers SD , Puli SR , Tjoa CW et al. T2 hypointensity in the deep grey matter of patients with multiple sclerosis, A quantitative magnetic resonance imaging study. Arch Neurol 2002; 59: 62—68.

Pujol J. , Junque C. , Vendrell P. , Grau JM , Marti-Vilalta JL , Olive C. et al. Biological significance of iron-related magnetic resonance imaging changes in the brain. Arch Neurol 1992; 49: 711—17.

Sled JG , Zijdenbos AP , Evans AC A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1998; 17: 87—97.

Jenkinson M. , Bannister P. , Brady M. , Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002; 17: 825—41.

Schenck JF , Zimmerman EA

High-field MRI of brain iron: birth of a biomarker?

NMR Biomed 2004; 17: 433—45.

Fisher E. , Rudick RA , Cutter G. , Baier M. , Miller D. , Weinstock-Guttman B. et al. Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients. Mult Scler 2000; 6: 373—77. 8. Brass SD, Benedict RHB, Weinstock-Guttman B,

Munschauer F. , Bakshi R. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 2006; 12: 437—44.

Zecca L. , Youdim Mbh , Riederer P. , Connor JR , Crichton RR Iron, brain ageing and neurodegenerative disorders. Nature Reviews/Neuroscience 2004; 5: 863—73.

10.

Dwork AJ , Schon EA , Herbert J. Nonidentical distribution of transferring and ferric iron in human brain. Neuroscience 1988; 27: 333—45.

11.

Connor JR , Menzies SL , Martin SM , Mufson EJ Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res 1990 ; 27: 595—611.

12.

LeVine SM , Chakrabarty A. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann NY Acad Sci 2004 ; 1012: 252—66.

13.

LeVine SM , Maiti S. , Emerson MR , Pedchenko TV Apoferritin attenuates experimental allergic encephalomyelitis in SJL mice . Dev Neurosci 2002; 24: 177—83.